BC
UTHR icon

Brookfield Corp’s United Therapeutics UTHR Stock Holding History

Brookfield Corp’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-28,525
Closed -$7.93M – 792
2022
Q4 		$7.93M Buy
28,525
+691
+2% +$174K 0.03% 178
2022
Q3 		$5.83M Sell
27,834
-5,293
-16% -$1.18M 0.02% 253
2022
Q2 		$7.81M Buy
33,127
+26,361
+390% +$5.36M 0.03% 186
2022
Q1 		$1.21M Sell
6,766
-2,079
-24% -$396K ﹤0.01% 472
2021
Q4 		$1.91M Buy
+8,845
New +$1.74M 0.01% 338

Other funds holding UTHR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return